The Centers for Medicare & Medicaid Services Friday finalized its decision to update Medicare’s national coverage policy for hospitals and physicians offering a transcatheter aortic valve replacement program to treat aortic stenosis, a condition in which the heart valve that pumps blood to the body becomes narrowed. Under the decision, Medicare will continue to cover the procedure under coverage with evidence development, but hospitals and physicians will have more flexibility to meet the requirements to perform the procedure, CMS said. The decision could expand the number of hospitals that are able to provide the service, which would increase patient access.   

Related News Articles

Perspective
Public
More than 34.1 million Americans were enrolled in a Medicare Advantage plan in 2025, accounting for 54% of all Medicare beneficiaries. We have seen enrollment…
Headline
A KFF analysis released Jan. 28 found that Medicare Advantage insurers made nearly 53 million prior authorization determinations in 2024, an increase…
Headline
The Centers for Medicare & Medicaid Services Jan. 26 released proposed changes to Medicare Advantage plan capitation rates and Part D payment policies for…
Headline
The AHA Jan. 26 expressed support and provided its perspective on certain provisions within the Centers for Medicare & Medicaid Services’ proposed…
Headline
The AHA Jan. 20 made recommendations to Congress on modernizing the Medicare Access and CHIP Reauthorization Act. Among the proposals, the AHA recommended…
Headline
The comment period for the Centers for Medicare & Medicaid Services' proposed rule for policies governing the Medicare Advantage and Part D programs for…